Dr. Manley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Boston, MA 02115Phone+1 617-632-4386Fax+1 617-632-4897
Education & Training
- Brown UniversityFellowship, Pediatric Hematology/Oncology, 2001 - 2004
- Tufts Medical CenterResidency, Pediatrics, 1998 - 2001
- Virginia Commonwealth University School of MedicineClass of 1998
Certifications & Licensure
- MA State Medical License 2004 - 2024
- ME State Medical License 2018 - 2018
- RI State Medical License 2005 - 2018
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 54 citationsMultiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.Shannon Coy, Rumana Rashid, Jia-Ren Lin, Ziming Du, Andrew M. Donson
Neuro-Oncology. 2018-07-05 - 289 citationsIntensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumorSusan N. Chi, Mary Ann Zimmerman, Xiaopan Yao, Kenneth J. Cohen, Peter C. Burger
Journal of Clinical Oncology. 2009-01-20 - 18 citationsParental needs for information related to neurocognitive late effects from pediatric cancer and its treatmentChristine Trask, Jennifer J.G. Welch, Peter E. Manley, Elissa Jelalian, Cindy L. Schwartz
Pediatric Blood & Cancer. 2009-02-01
Press Mentions
- Fewer Childhood Cancer Survivors Dying from 'Late' EffectsJanuary 13th, 2016
- Long-Term Survival Among Patients with Most Common Childhood Brain Tumor Is High; Lower if Treatment Included RadiationFebruary 3rd, 2014
- Mutation Discovery May Improve Treatment for Rare Brain Tumor TypeJanuary 12th, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: